Clinical Trials Browser

INDUSTRY × Leiomyosarcoma × Doxorubicin × Clear all

NCT06088290 2026-03-11

SaLuDo

Phase 3 Recruiting

Leiomyosarcoma, Neoplasms

NCT02451943 2025-07-15

ANNOUNCE

Phase 3 Completed

509 enrolled 23 charts

Leiomyosarcoma, Liposarcoma, Sarcoma, Histiocytoma, Malignant Fibrous

NCT04996004 2024-12-11

TTI-621-03

Phase 2 Terminated

76 enrolled 53 charts

Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Sarcoma, Dermatofibrosarcoma

NCT03420014 2023-10-10

FIBROSARC US

Phase 2 Unknown

Leiomyosarcoma